Pharmaceuticals
Especially with respect to production of medicinal preparations, pharmaceutical companies are increasingly resorting to biological insights. Although chemically produced medicine still represents the largest share on the German pharma market, so-called biopharmaceuticals are increasingly gaining ground. Their sales of 5.6 billion euros are currently 21% of the market, with a rising trend. These drugs consist of biomolecules that are so large that they cannot be manufactured by man – or only at prohibitive cost.